Many small steps towards a COVID-19 drug

A large-scale screening campaign has yielded dozens of crystal structures of small molecule fragments that bind to the main protease of SARS-CoV-2. The global research community is encouraged to pursue these as drug discovery starting points for COVID-19.

Detalles Bibliográficos
Autor principal: Erlanson, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541474/
https://www.ncbi.nlm.nih.gov/pubmed/33028832
http://dx.doi.org/10.1038/s41467-020-18710-3
_version_ 1783591402839474176
author Erlanson, Daniel A.
author_facet Erlanson, Daniel A.
author_sort Erlanson, Daniel A.
collection PubMed
description A large-scale screening campaign has yielded dozens of crystal structures of small molecule fragments that bind to the main protease of SARS-CoV-2. The global research community is encouraged to pursue these as drug discovery starting points for COVID-19.
format Online
Article
Text
id pubmed-7541474
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75414742020-10-19 Many small steps towards a COVID-19 drug Erlanson, Daniel A. Nat Commun Comment A large-scale screening campaign has yielded dozens of crystal structures of small molecule fragments that bind to the main protease of SARS-CoV-2. The global research community is encouraged to pursue these as drug discovery starting points for COVID-19. Nature Publishing Group UK 2020-10-07 /pmc/articles/PMC7541474/ /pubmed/33028832 http://dx.doi.org/10.1038/s41467-020-18710-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Comment
Erlanson, Daniel A.
Many small steps towards a COVID-19 drug
title Many small steps towards a COVID-19 drug
title_full Many small steps towards a COVID-19 drug
title_fullStr Many small steps towards a COVID-19 drug
title_full_unstemmed Many small steps towards a COVID-19 drug
title_short Many small steps towards a COVID-19 drug
title_sort many small steps towards a covid-19 drug
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541474/
https://www.ncbi.nlm.nih.gov/pubmed/33028832
http://dx.doi.org/10.1038/s41467-020-18710-3
work_keys_str_mv AT erlansondaniela manysmallstepstowardsacovid19drug

Ejemplares similares